Human cytomegalovirus latency and reactivation in and beyond the myeloid lineage

Future Virology

Volumn 9, Issue 6, 2014, Pages 557-563

  Sinclair, John ^a   Poole, Emma ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

human cytomegalovirus; latency; myeloid; reactivation

Indexed keywords

TRANSCRIPTION FACTOR GATA 2; VIRUS DNA;

BONE MARROW CELL; CELL DIFFERENTIATION; CELL LINEAGE; CHROMATIN; CYTOMEGALOVIRUS INFECTION; GENE CONTROL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; MYELOID PROGENITOR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; VIRUS CARRIER; VIRUS GENOME; VIRUS LATENCY; VIRUS REACTIVATION;

EID: 84905228497     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.14.34     Document Type: Review

References (68)

1. Rook AH. Interactions of cytomegalovirus with the human immune system. Rev. Infect. Dis. 10(Suppl. 3), S460-S467 (1988).
2. Zaia JA. The biology of human cytomegalovirus infection after bone marrow transplantation. Int. J. Cell Cloning 4(Suppl. 1), 135-154 (1986).
3. Orloff SL, Hwee YK, Kreklywich C et al. Cytomegalovirus latency promotes cardiac lymphoid neogenesis and accelerated allograft rejection in CMV naive recipients. Am. J. Transplant. 11(1), 45-55 (2012).
4. Comar M, Delbue S, Lepore L et al. Latent viral infections in young patients with infammatory diseases treated with biological agents: prevalence of JC virus genotype 2. J. Med. Virol. 85(4), 716-722 (2013).
5. Sissons JG, Sinclair JH, Borysiewicz LK. Pathogenesis of human cytomegalovirus disease and the kidney. Kidney Int. Suppl. 35, S8-S12 (1991).
6. Yeager AS. Transfusion-acquired cytomegalovirus infection in newborn infants. Am. J. Dis. Child. 128(4), 478-483 (1974).
7. Adler SP. Transfusion-associated cytomegalovirus infections. Rev. Infect. Dis. 5(6), 977-993 (1983).
8. Tolpin MD, Stewart JA, Warren D et al. Transfusion transmission of cytomegalovirus confrmed by restriction endonuclease analysis. J. Pediatr. 107(6), 953-956 (1985).
9. Jordan MC. Latent infection and the elusive cytomegalovirus. Rev. Infect. Dis. 5(2), 205-215 (1983).
10. Hansen LL, Nieuwenhuis I, Hoffken G, Heise W. [Retinitis in AIDS patients: diagnosis, follow-up and treatment]. Fortschr. Ophthalmol. 86(3), 232-238 (1989).
11. Schrier RD, Nelson JA, Oldstone MB. Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science 230 (4729), 1048-1051 (1985).
12. Stanier P, Taylor DL, Kitchen AD, Wales N, Tryhorn Y, Tyms AS. Persistence of cytomegalovirus in mononuclear cells in peripheral blood from blood donors. BMJ 299(6704), 897-898 (1989).
13. Bevan IS, Daw RA, Day PJ, Ala FA, Walker MR. Polymerase chain reaction for detection of human cytomegalovirus infection in a blood donor population. Br. J. Haematol. 78(1), 94-99 (1991).
14. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72 (Pt 9), 2059-2064 (1991).
15. Mendelson M, Monard S, Sissons P, Sinclair J. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77 (Pt 12), 3099-3102 (1996).
16. Larsson S, Soderberg-Naucler C, Wang FZ, Moller E. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time. Transfusion 38(3), 271-278 (1998).
17. Slobedman B, Mocarski ES. Quantitative analysis of latent human cytomegalovirus. J. Virol. 73(6), 4806-4812 (1999).
18. Ibanez CE, Schrier R, Ghazal P, Wiley C, Nelson JA. Human cytomegalovirus productively infects primary differentiated macrophages. J. Virol. 65(12), 6581-6588 (1991).
19. Lathey JL, Spector SA. Unrestricted replication of human cytomegalovirus in hydrocortisone-treated macrophages. J. Virol. 65, 6371-6375 (1991).
20. Soderberg-Naucler C, Fish KN, Nelson JA. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91(1), 119-126 (1997).
21. Reeves MB, Lehner PJ, Sissons JG, Sinclair JH. An in vitro model for the regulation of human cytomegalovirus latency and reactivation in dendritic cells by chromatin remodelling. J. Gen. Virol. 86 (P t 11), 2949-2954 (2005).
22. Reeves MB, Macary PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc. Natl Acad. Sci. USA 102 (11), 4140-4145 (2005).
23. Maciejewski JP, Bruening EE, Donahue RE, Mocarski ES, Young NS, St Jeor SC. Infection of hematopoietic progenitor cells by human cytomegalovirus. Blood 80(1), 170-178 (1992).
24. Kondo K, Kaneshima H, Mocarski ES. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl Acad. Sci. USA 91(25), 11879-11883 (1994).
25. Minton EJ, Tysoe C, Sinclair JH, Sissons JG. Human cytomegalovirus infection of the monocyte/macrophage lineage in bone marrow. J. Virol. 68(6), 4017-4021 (1994).
26. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc. Natl Acad. Sci. USA 95(7), 3937-3942 (1998).
27. Goodrum FD, Jordan CT, High K, Shenk T. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl Acad. Sci. USA 99(25), 16255-16260 (2002).
28. + monocytes. Proc. Natl Acad. Sci USA 107(46), 20039-20044 (2011).
29. + cell populations. J. Virol. 87(17), 9802-9812 (2013).
30. Keyes LR, Bego MG, Soland M, St Jeor S. Cyclophilin A is required for effcient human cytomegalovirus DNA replication and reactivation. J. Gen. Virol. 93(Pt 4), 722-732 (2012).
31. Penkert RR, Kalejta RF. Human embryonic stem cell lines model experimental human cytomegalovirus latency. MBio 4(3), e00298-e00213 (2013).
32. Murphy EA, Streblow DN, Nelson JA, Stinski MF. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J. Virol. 74(15), 7108-7118 (2000).
33. Murphy Jc FW, Verdin E, Sinclair JH. Control of cytomegalovirus lytic gene expression by histone acetylation. EMBO J. 21, 1112-1120 (2002).
34. Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: are chromatin modifying enzymes the key? Gene 236(2), 197-208 (1999).
35. Pizzorno MC. Nuclear cathepsin B-like protease cleaves transcription factor YY1 in differentiated cells. Biochim. Biophys. Acta 1536(1), 31-42 (2001).
36. Bain M, Mendelson M, Sinclair J. Ets-2 Repressor Factor (ERF) mediates repression of the human cytomegalovirus major immediate-early promoter in undifferentiated non-permissive cells. J. Gen. Virol. 84(Pt 1), 41-49 (2003).
37. Wright E, Bain M, Teague L, Murphy J, Sinclair J. Ets-2 repressor factor recruits histone deacetylase to silence human cytomegalovirus immediate-early gene expression in non-permissive cells. J. Gen. Virol. 86(Pt 3), 535-544 (2005).
38. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181(1), 698-711 (2008).
39. + cells. J. Virol. 84(11), 5594-5604 (2013).
40. +) cells. PLoS Pathog. 9(5), e1003366 (2013).
41. +) cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93(1), 394-398 (1999).
42. Miyamoto T. Role of osteoclasts in regulating hematopoietic stem and progenitor cells. World J. Orthop. 4(4), 198-206 (2013).
43. Tsai FY, Orkin SH. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89 (10), 3636-3643 (1997).
44. De Pater E, Kaimakis P, Vink CS et al. Gata2 is required for HSC generation and survival. J. Exp. Med. 210 (13), 2843-2850 (2013).
45. Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J. The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specifc manner. J. Virol. 87(8), 4261-4271 (2013).
46. Poole E, Mcgregor Dallas SR, Colston J, Joseph RS, Sinclair J. Virally induced changes in cellular microRNAs maintain latency of human cytomegalovirus in CD34 progenitors. J. Gen. Virol. 92(Pt 7), 1539-1549 (2011).
47. Reeves MB, Breidenstein A, Compton T. Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cells. Proc. Natl Acad. Sci. USA 109(2), 588-593 (2012).
48. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79 (17), 11022-11034 (2005).
49. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110(3), 937-945 (2007).
50. Jenkins C, Abendroth A, Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78 (3), 1440-1447 (2004).
51. + T-cell recognition of latently infected cells: implications for virus elimination during l atency. Blood 114(19), 4128-4137 (2009).
52. +) cells. PLoS ONE 7(12), e52827 (2013).
53. Neote K, Digregorio D, Mak JY, Horuk R, Schall TJ. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor. Cell 72(3), 415-425 (1993).
54. Benedict CA, Butrovich KD, Lurain NS et al. A novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J. Immunol. 162, 6967-6970 (1999).
55. Cheung TC, Humphreys IR, Potter KG et al. Evolutionary divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc. Natl Acad. Sci. USA 37, 13218-13223. (2005).
56. Poole E, King CA, Sinclair JH, Alcami A. The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. EMBO J. 25(18), 4390-4399 (2006).
57. Reeves MB, Sinclair JH. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifcations at a latent promoter. J. Gen. Virol. 91(Pt 3), 599-604 (2010).
58. Qin Q, Penkert RR, Kalejta RF. Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency. J. Virol. 87(17), 9886-9894 (2013).
59. + T-cell migration and suppression of effector function. Proc. Natl Acad. Sci. USA 109 (36), 14538-14543 (2012).
60. Weekes MP, Tan SY, Poole E et al. Latency-associated degradation of the MRP1 drug transporter during latent human cytomegalovirus infection. Science 340(6129), 199-202 (2013).
61. + heart progenitors with VEGF modifed mRNA. Cell Res. 23(10), 1172-1186 (2013).
62. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183(4), 1797-1806 (1996).
63. +) cells. Br. J. Haematol. 115(1), 186-194 (2001).
64. Sinzger C, Grefte A, Plachter B, Gouw AS, The TH, Jahn G. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J. Gen. Virol. 76 (Pt 4), 741-750 (1995).
65. Jarvis MA, Nelson JA. Human cytomegalovirus persistence and latency in endothelial cells and macrophages. Curr. Opin. Microbiol. 5(4), 403-407 (2002).
66. Reeves MB, Coleman H, Chadderton J, Goddard M, Sissons JG, Sinclair JH. Vascular endothelial and smooth muscle cells are unlikely to be major sites of latency of human cytomegalovirus in vivo. J. Gen. Virol. 85(Pt 11), 3337-3341 (2004).
67. Belzile JP, Stark TJ, Yeo GW, Spector DH. Human cytomegalovirus infection of human embryonic stem cell-derived primitive neural stem cells is restricted at several steps but leads to the persistence of viral DNA. J. Virol. 88(8), 4021-4039 (2014).
68. Duan YL, Ye HQ, Zavala AG et al. Maintenance of large numbers of virus genomes in human cytomegalovirus-infected T98G glioblastoma cells. J. Virol. 88(7), 3861-3873 (2014).